Antimicrobial drug pricing
Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.
Saved in:
| Main Authors: | Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra, Beth Woods, Christopher Little, Tom Rhodes, Harriet Tuson, Zeshan Riaz, Tom Ashfield, Michael Corley, Ioannis Baltas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-024-00594-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shortage of essential antimicrobials: a major challenge to global health security
by: Esmita Charani, et al.
Published: (2021-11-01) -
Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression.
by: Navjot Kaur, et al.
Published: (2014-01-01) -
A multicentric survey on antimicrobial use and hospital acquired infections among patients admitted in tertiary care centers in India
by: Prof Nusrat Shafiq, et al.
Published: (2025-03-01) -
Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India
by: Sharonjeet Kaur, et al.
Published: (2014-01-01) -
Population pharmacokinetic study of colistin for dose optimization in patients with acute on chronic liver failure (ACLF) patients
by: Dr Ritika Bhandari, et al.
Published: (2025-03-01)